193 related articles for article (PubMed ID: 10447239)
21. Effects of galactolipid elimination on oligodendrocyte development and myelination.
Marcus J; Dupree JL; Popko B
Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
[TBL] [Abstract][Full Text] [Related]
22. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve.
Martini R; Schachner M
J Cell Biol; 1986 Dec; 103(6 Pt 1):2439-48. PubMed ID: 2430983
[TBL] [Abstract][Full Text] [Related]
23. Evidence for an early role for myelin-associated glycoprotein in the process of myelination.
Owens GC; Bunge RP
Glia; 1989; 2(2):119-28. PubMed ID: 2470674
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemical localization of the myelin-associated glycoprotein. Fact or artifact?
Trapp BD; Quarles RH
J Neuroimmunol; 1984 Jul; 6(4):231-49. PubMed ID: 6203932
[TBL] [Abstract][Full Text] [Related]
25. New perspectives on the function of myelin galactolipids.
Coetzee T; Suzuki K; Popko B
Trends Neurosci; 1998 Mar; 21(3):126-30. PubMed ID: 9530920
[TBL] [Abstract][Full Text] [Related]
26. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes.
Trapp BD; Andrews SB; Cootauco C; Quarles R
J Cell Biol; 1989 Nov; 109(5):2417-26. PubMed ID: 2478568
[TBL] [Abstract][Full Text] [Related]
27. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes.
Dyer CA; Benjamins JA
J Neurosci Res; 1991 Dec; 30(4):699-711. PubMed ID: 1787543
[TBL] [Abstract][Full Text] [Related]
28. Novel method for studying myelination in vivo reveals that EDTA is a potent inhibitor of myelin protein and mRNA expression during development of the rat sciatic nerve.
Meintanis S; Thomaidou D; Jessen KR; Mirsky R; Matsas R
Glia; 2004 Nov; 48(2):132-44. PubMed ID: 15378656
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebroside.
Ranscht B; Wood PM; Bunge RP
J Neurosci; 1987 Sep; 7(9):2936-47. PubMed ID: 3625279
[TBL] [Abstract][Full Text] [Related]
30. Nfasc155H and MAG are specifically susceptible to detergent extraction in the absence of the myelin sphingolipid sulfatide.
Pomicter AD; Deloyht JM; Hackett AR; Purdie N; Sato-Bigbee C; Henderson SC; Dupree JL
Neurochem Res; 2013 Dec; 38(12):2490-502. PubMed ID: 24081651
[TBL] [Abstract][Full Text] [Related]
31. Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions.
Marcus J; Dupree JL; Popko B
J Cell Biol; 2002 Feb; 156(3):567-77. PubMed ID: 11827985
[TBL] [Abstract][Full Text] [Related]
32. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
33. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination.
Owens GC; Bunge RP
Glia; 1990; 3(2):118-24. PubMed ID: 1692007
[TBL] [Abstract][Full Text] [Related]
34. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
35. 04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP.
Mirsky R; Dubois C; Morgan L; Jessen KR
Development; 1990 May; 109(1):105-16. PubMed ID: 2170096
[TBL] [Abstract][Full Text] [Related]
36. Immune-mediated demyelination--immunopathological basis for electrophysiological changes.
Saida T; Saida K
Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():56-69. PubMed ID: 6962042
[TBL] [Abstract][Full Text] [Related]
37. The role and metabolism of sulfatide in the nervous system.
Eckhardt M
Mol Neurobiol; 2008; 37(2-3):93-103. PubMed ID: 18465098
[TBL] [Abstract][Full Text] [Related]
38. Temporal and quantitative expression of the myelin-associated lipids, ethanolamine plasmalogen, galactocerebroside, and sulfatide, in the differentiating CG-4 glial cell line.
Bichenkov E; Ellingson JS
Neurochem Res; 1999 Dec; 24(12):1549-56. PubMed ID: 10591405
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of oligodendrocyte differentiation by galactosphingolipids.
Bansal R; Winkler S; Bheddah S
J Neurosci; 1999 Sep; 19(18):7913-24. PubMed ID: 10479693
[TBL] [Abstract][Full Text] [Related]
40. Adult CST-null mice maintain an increased number of oligodendrocytes.
Shroff SM; Pomicter AD; Chow WN; Fox MA; Colello RJ; Henderson SC; Dupree JL
J Neurosci Res; 2009 Nov; 87(15):3403-14. PubMed ID: 19224580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
